{
  "nodes": [
    {
      "id": "N1",
      "label": "Step 1",
      "customData": {
        "node_id": "A",
        "node_step_index": 0,
        "content": "57-year-old Italian man with recurrence of stage IV non-small-cell lung cancer (NSCLC) post hemianopsy, diagnosed eight months prior as oligometastatic adenocarcinoma in the right lung with solitary brain metastasis (cT2aN0M1b).",
        "clinical_data": {
          "diagnoses": [
            {
              "code": "C0024117",
              "label": "Non-Small Cell Lung Carcinoma",
              "status": "active",
              "onset_date": null
            },
            {
              "code": "C0001547",
              "label": "Adenocarcinoma",
              "status": "active",
              "onset_date": null
            },
            {
              "code": "C0239974",
              "label": "Brain Metastasis",
              "status": "active",
              "onset_date": null
            }
          ]
        }
      }
    },
    {
      "id": "N2",
      "label": "Step 2",
      "customData": {
        "node_id": "B",
        "node_step_index": 1,
        "content": "Patient consulted 3 weeks after first cycle of pembrolizumab, presenting with dyspnea, pain in the right calf muscle, swelling of the lower limbs, and inability to walk for 2 days. Also reported growing general discomfort, fatigue, and bilateral weakness of the legs with exercise limitation since first pembrolizumab administration.",
        "clinical_data": {
          "HPI": [
            {
              "summary": "Patient consulted 3 weeks after first cycle of pembrolizumab, presenting with dyspnea, pain in the right calf muscle, swelling of the lower limbs, and inability to walk for 2 days. Also reported growing general discomfort, fatigue, and bilateral weakness of the legs with exercise limitation since first pembrolizumab administration.",
              "duration": "3 weeks",
              "onset": "3 weeks after first cycle of pembrolizumab",
              "progression": "gradual",
              "associated_symptoms": [
                "Dyspnea",
                "Pain in the right calf muscle",
                "Swelling of the lower limbs",
                "Inability to walk",
                "General discomfort",
                "Fatigue",
                "Bilateral weakness of the legs",
                "Exercise limitation"
              ],
              "exacerbating_factors": [
                "Exercise"
              ]
            }
          ],
          "medications": [
            {
              "drug": "Pembrolizumab",
              "start_date": null,
              "end_date": null,
              "indication": null
            }
          ]
        }
      }
    },
    {
      "id": "N3",
      "label": "Step 3",
      "customData": {
        "node_id": "C",
        "node_step_index": 2,
        "content": "Next generation sequencing revealed TP53 mutation. Fluorescence in situ hybridization for ALK was negative, but immunohistochemistry for the PD-L1 was 100% positive.",
        "clinical_data": {
          "labs": [
            {
              "test": "Next generation sequencing",
              "value": "TP53 mutation",
              "unit": null,
              "flag": "abnormal",
              "reference_range": null,
              "timestamp": null
            },
            {
              "test": "Fluorescence in situ hybridization for ALK",
              "value": "negative",
              "unit": null,
              "flag": "normal",
              "reference_range": null,
              "timestamp": null
            },
            {
              "test": "immunohistochemistry for the PD-L1",
              "value": "100% positive",
              "unit": "%",
              "flag": "abnormal",
              "reference_range": null,
              "timestamp": null
            }
          ]
        }
      }
    },
    {
      "id": "N4",
      "label": "Step 4",
      "customData": {
        "node_id": "D",
        "node_step_index": 3,
        "content": "Cerebral lesion was surgically resected, followed by stereotactic radiotherapy (5 \u00d7 7 Gy) at the resection site.",
        "clinical_data": {
          "procedures": [
            {
              "name": "Surgical resection",
              "approach": "open",
              "location": "Cerebral lesion",
              "outcome": "resected"
            },
            {
              "name": "Stereotactic radiotherapy",
              "approach": "other",
              "location": "resection site",
              "outcome": "completed"
            }
          ]
        }
      }
    },
    {
      "id": "N5",
      "label": "Step 5",
      "customData": {
        "node_id": "E",
        "node_step_index": 4,
        "content": "Primary tumor was surgically removed by video-assisted thoracoscopic surgery (VATS) with inferior right lobectomy and four cycles of adjuvant chemotherapy (cisplatin\u2013pemetrexed combination) were given.",
        "clinical_data": {
          "procedures": [
            {
              "name": "Video-assisted thoracoscopic surgery",
              "approach": "endoscopic",
              "date": null,
              "location": "right lung",
              "performed_by": null,
              "outcome": null
            },
            {
              "name": "Lobectomy",
              "approach": "open",
              "date": null,
              "location": "inferior right lobe",
              "performed_by": null,
              "outcome": null
            }
          ],
          "medications": [
            {
              "drug": "cisplatin",
              "dosage": null,
              "frequency": null,
              "modality": "IV",
              "start_date": null,
              "end_date": null,
              "indication": "adjuvant chemotherapy"
            },
            {
              "drug": "pemetrexed",
              "dosage": null,
              "frequency": null,
              "modality": "IV",
              "start_date": null,
              "end_date": null,
              "indication": "adjuvant chemotherapy"
            }
          ]
        }
      }
    },
    {
      "id": "N6",
      "label": "Step 6",
      "customData": {
        "node_id": "F",
        "node_step_index": 5,
        "content": "Disease progression with new pleural metastasis and suspect pancreatic lesion at the end of adjuvant treatment. Pembrolizumab (2 mg/kg) in a 3-weekly cycle was started for second-line treatment. Patient is an ex-smoker (45 pack-years). Clinical examination at presentation confirmed a swelling of the lower legs, right more then left, with pain in the right calf.",
        "clinical_data": {
          "medications": [
            {
              "drug": "Pembrolizumab",
              "dosage": "2 mg/kg",
              "frequency": "3-weekly",
              "modality": "IV",
              "start_date": null,
              "end_date": null,
              "indication": "metastatic cancer"
            }
          ],
          "diagnoses": [
            {
              "code": "http://purl.bioontology.org/ontology/ICD10/C78.0",
              "label": "Secondary malignant neoplasm of lung",
              "status": "active",
              "onset_date": null
            },
            {
              "code": "http://purl.bioontology.org/ontology/ICD10/C25",
              "label": "Malignant neoplasm of pancreas",
              "status": "suspected",
              "onset_date": null
            }
          ],
          "social_history": [
            {
              "category": "smoking",
              "status": "past",
              "description": "45 pack-years"
            }
          ],
          "HPI": [
            {
              "summary": "Swelling of the lower legs, right more than left, with pain in the right calf",
              "duration": null,
              "onset": null,
              "progression": "unknown",
              "associated_symptoms": [
                "Pain"
              ],
              "alleviating_factors": [],
              "exacerbating_factors": []
            }
          ]
        }
      }
    },
    {
      "id": "N7",
      "label": "Step 7",
      "customData": {
        "node_id": "G",
        "node_step_index": 6,
        "content": "Auscultation of heart and lungs was normal. Vital parameters were normal. Blood tests revealed elevated creatine kinase (CK) 11796 U/l (ref. <190 U/l), and elevated CK cardiac isoenzyme 112.5 \u03bcg/l (ref.",
        "clinical_data": {
          "vitals": [],
          "labs": [
            {
              "test": "Creatine Kinase",
              "value": "11796",
              "unit": "U/l",
              "flag": "abnormal",
              "reference_range": "<190 U/l"
            },
            {
              "test": "Creatine Kinase Cardiac Isoenzyme",
              "value": "112.5",
              "unit": "\u03bcg/l",
              "flag": "abnormal"
            }
          ]
        }
      }
    },
    {
      "id": "N8",
      "label": "Step 8",
      "customData": {
        "node_id": "H",
        "node_step_index": 7,
        "content": "Blood tests revealed elevated creatine kinase (CK) 11796 U/l (ref. <190 U/l), elevated CK cardiac isoenzyme 112.5 \u03bcg/l (ref. <6.2 \u03bcg/l), troponin 0.183 \u03bcg/l (ref. <0.013 \u03bcg/l). Liver function enzymes and LDH were also disrupted and c-reactive protein was increased to 35 mg/l. Electrocardiogram (ECG) showed sinus rhythm with new small biphasic T-waves in V2 to V5.",
        "clinical_data": {
          "labs": [
            {
              "test": "Creatine Kinase",
              "value": "11796",
              "unit": "U/l",
              "flag": "abnormal",
              "reference_range": "<190 U/l"
            },
            {
              "test": "Creatine Kinase Cardiac Isoenzyme",
              "value": "112.5",
              "unit": "\u03bcg/l",
              "flag": "abnormal",
              "reference_range": "<6.2 \u03bcg/l"
            },
            {
              "test": "Troponin",
              "value": "0.183",
              "unit": "\u03bcg/l",
              "flag": "abnormal",
              "reference_range": "<0.013 \u03bcg/l"
            },
            {
              "test": "Lactate dehydrogenase measurement",
              "flag": "abnormal"
            },
            {
              "test": "C-Reactive Protein",
              "value": "35",
              "unit": "mg/l",
              "flag": "abnormal"
            }
          ],
          "imaging": [
            {
              "type": "Electrocardiography",
              "modality": "ECG",
              "finding": "sinus rhythm with new small biphasic T-waves in V2 to V5"
            }
          ]
        }
      }
    },
    {
      "id": "N9",
      "label": "Step 9",
      "customData": {
        "node_id": "I",
        "node_step_index": 8,
        "content": "CT of the chest: no pulmonary embolism or other causes of dyspnea. Venous duplex scan of the lower limbs: no venous thrombosis in the pelvis or legs. Transthoracic echocardiography (TTE): normotrophic and normocontractile heart with normal systolic left and right ventricular function, without significant valvular disease. Nuclear magnetic resonance (NMR) of the heart: normal.",
        "clinical_data": {
          "imaging": [
            {
              "type": "Chest CT",
              "body_part": "Thorax",
              "modality": "CT",
              "finding": "no pulmonary embolism or other causes of dyspnea"
            },
            {
              "type": "Venous duplex scan",
              "body_part": "Lower limbs",
              "modality": "Ultrasound",
              "finding": "no venous thrombosis in the pelvis or legs"
            },
            {
              "type": "Transthoracic echocardiography",
              "body_part": "Heart",
              "modality": "Ultrasound",
              "finding": "normotrophic and normocontractile heart with normal systolic left and right ventricular function, without significant valvular disease"
            },
            {
              "type": "Nuclear magnetic resonance",
              "body_part": "Heart",
              "modality": "MRI",
              "finding": "normal"
            }
          ]
        }
      }
    },
    {
      "id": "N10",
      "label": "Step 10",
      "customData": {
        "node_id": "J",
        "node_step_index": 9,
        "content": "Soft tissue ultrasound of the right lower leg: nonspecific distortion of the architecture of the medial gastrocnemius muscle",
        "area": "necrotizing myositis. Gastrocnemius muscle biopsy showed Hematoxylin\u2013eosin staining: extensive lymphohistiocytic infiltrate of the individual muscle fibers and muscle fiber",
        "clinical_data": {
          "imaging": [
            {
              "type": "26435003",
              "body_part": "10964003",
              "modality": "Ultrasound",
              "finding": "nonspecific distortion of the architecture of the medial gastrocnemius muscle",
              "impression": "nonspecific distortion of the architecture of the medial gastrocnemius muscle"
            }
          ]
        }
      }
    }
  ],
  "edges": [
    {
      "from": "N1",
      "to": "N2",
      "data": {
        "edge_id": "A_to_B",
        "branch_flag": true,
        "content": "Transition from initial diagnosis to presentation with dyspnea, calf pain, lower limb swelling, inability to walk, general discomfort, fatigue, and bilateral leg weakness after pembrolizumab.",
        "transition_event": {
          "trigger_type": "medication_change",
          "trigger_entities": [
            "C0025598"
          ],
          "change_type": "addition",
          "target_domain": "symptom"
        }
      }
    },
    {
      "from": "N2",
      "to": "N3",
      "data": {
        "edge_id": "B_to_C",
        "branch_flag": true,
        "content": "Transition from clinical presentation to genetic and immunohistochemical findings.",
        "transition_event": {
          "trigger_type": "lab_change",
          "trigger_entities": [
            "C0578577",
            "C4721489",
            "C4023424"
          ],
          "change_type": "reinterpretation",
          "target_domain": "diagnosis"
        }
      }
    },
    {
      "from": "N3",
      "to": "N4",
      "data": {
        "edge_id": "C_to_D",
        "branch_flag": true,
        "content": "Transition from genetic/immunohistochemical findings to surgical resection and stereotactic radiotherapy of cerebral lesion.",
        "transition_event": {
          "trigger_type": "procedure",
          "trigger_entities": [
            "C0036384",
            "C0457975"
          ],
          "change_type": "addition",
          "target_domain": "procedure"
        }
      }
    },
    {
      "from": "N4",
      "to": "N5",
      "data": {
        "edge_id": "D_to_E",
        "branch_flag": true,
        "content": "Transition from cerebral lesion treatment to primary tumor removal and adjuvant chemotherapy.",
        "transition_event": {
          "trigger_type": "procedure",
          "trigger_entities": [
            "C0042794",
            "C0023893"
          ],
          "change_type": "addition",
          "target_domain": "procedure"
        }
      }
    },
    {
      "from": "N5",
      "to": "N6",
      "data": {
        "edge_id": "E_to_F",
        "branch_flag": true,
        "content": "Transition from adjuvant treatment to disease progression, new metastasis, and initiation of pembrolizumab as second-line treatment.",
        "transition_event": {
          "trigger_type": "medication_change",
          "trigger_entities": [
            "C0025598"
          ],
          "change_type": "addition",
          "target_domain": "medication"
        }
      }
    },
    {
      "from": "N6",
      "to": "N7",
      "data": {
        "edge_id": "F_to_G",
        "branch_flag": true,
        "content": "Transition from disease progression and pembrolizumab initiation to clinical examination and initial blood test results.",
        "transition_event": {
          "trigger_type": "symptom_onset",
          "trigger_entities": [
            "C0009765",
            "C0231248"
          ],
          "change_type": "progression",
          "target_domain": "symptom"
        }
      }
    },
    {
      "from": "N7",
      "to": "N8",
      "data": {
        "edge_id": "G_to_H",
        "branch_flag": true,
        "content": "Transition from initial blood test results to more comprehensive blood test results and ECG findings.",
        "transition_event": {
          "trigger_type": "lab_change",
          "trigger_entities": [
            "C0010300",
            "C0041034",
            "C0012738"
          ],
          "change_type": "progression",
          "target_domain": "lab"
        }
      }
    },
    {
      "from": "N8",
      "to": "N9",
      "data": {
        "edge_id": "H_to_I",
        "branch_flag": true,
        "content": "Transition from abnormal lab results and ECG to negative imaging results (CT, venous duplex, TTE"
      }
    }
  ]
}